Hyperandrogenism due to a testosterone-secreting sertoli-leydig cell tumor associated with a dehydroepiandrosterone sulfate-secreting adrenal adenoma in a postmenopausal woman: Case presentation and review of literature

Endocrine Practice

Volumn 15, Issue 2, 2009, Pages 149-152

  Herrera, Jorge D ^a   Davidson, Jaime A ^b   Mestman, Jorge H ^c,d  

^a Universidad Catolica de Cuyo   (Argentina)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRASTERONE SULFATE; TESTOSTERONE;

ADRENAL CORTEX ADENOMA; ADRENALECTOMY; ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERANDROGENISM; LEYDIG CELL TUMOR; OVARIECTOMY; OVARY TUMOR; POSTMENOPAUSE; SERTOLI CELL TUMOR; TESTOSTERONE RELEASE; TRANSVAGINAL ECHOGRAPHY; ALOPECIA; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; REVIEW;

ADRENOCORTICAL ADENOMA; ALOPECIA; DEHYDROEPIANDROSTERONE SULFATE; FEMALE; HUMANS; HYPERANDROGENISM; LEYDIG CELL TUMOR; MIDDLE AGED; POSTMENOPAUSE; TESTOSTERONE;

EID: 67549088810     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP.15.2.149     Document Type: Article

References (13)

1. Azziz R, Sanchez LA, Knochenhauer ES, et al. Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab. 2004;89: 453-462.
2. Derksen J, Nagesser SK, Meinders AE, Haak HR, van de Valde CJ. Identification of virilizing adrenal tumors in hirsute women. N Engl J Med. 1994;331:968-973.
3. Terzolo M, Ali A, Osella G, et al. The value of dehydroepiandrosterone sulfate measurement in the differentiation between benign and malignant adrenal masses. Eur J Endocrinol. 2000;142:611-617.
4. Del Gaudio AD, Del Gaudio GA. Virilizing adrenocortical tumors in adult women: report of 10 patients, 2 of whom each had a tumor secreting only testosterone. Cancer. 1993;72:1997-2003.
5. Regnier C, Bennet A, Malet D, et al. Intraoperative testosterone assay for virilizing ovarian tumor topographic assessment: report of a Leydig cell tumor of the ovary in a premenopausal woman with an adrenal incidentaloma. J Clin Endocrinol Metab. 2002;87:3074-3077.
6. Ryan JJ, Rezkalla MA, Rizk SN, Peterson KG, Wiebe RH. Testosterone-secreting adrenal adenoma that contained crystalloids of Reinke in an adult female patient. Mayo Clin Proc. 1995;70:380-383.
7. O'Driscoll JB, Mamtora H, Higginson J, Pollock A, Kane J, Anderson DC. A prospective study of the prevalence of clear-cut endocrine disorders and polycystic ovaries in 350 patients presenting with hirsutism or androgenic alopecia. Clin Endocrinol (Oxf). 1994;41:231-236.
8. Waggoner W, Boots LR, Azziz R. Total testosterone and DHEAS levels as predictors of androgen-secreting neoplasms: a populational study. Gynecol Endocrinol. 1999; 13:394-400.
9. Young RH. Ovarian tumors other than those of surface epithelial-stromal type. Hum Pathol. 1991;22:763-775.
10. Barth JH, Jenkins M, Beichetz PE. Ovarian hyperthecosis, diabetes and hirsuties in post-menopausal women. Clin Endocrinol (Oxf). 1997;46:123-128.
11. Young RH, Scully RE. Ovarian steroid cell tumors associated with Cushing's syndrome: a report of three cases. Int J Gynecol Pathol. 1987;6:40-48.
12. Gorgojo JJ, Almodóvar F, López E, Vicente del Cerro J, Tejerina E, Donnay S. Coincidental diagnosis of an occult hilar steroid cell tumor of the ovary and a cortisolsecreting adrenal adenoma in a 49-year-old woman with severe hyperandrogenism. Fertil Steril. 2003;80:1504-1507.
13. Diab DL, Faiman C, Siperstein AE, Grossman WF, Rabinowitz LO, Hamrahiam AH. Virilizing ovarian Leydig cell tumor in a woman with subclinical Cushing syndrome. Endocr Pract. 2008;14:358-361.